Brief: Intelligent Bio Solutions Partners With Cliantha Research To Conduct Clinical Study As Part Of FDA 510(K) Pathway
28/02/2024 13:36
Feb 28 (Reuters) - Intelligent Bio Solutions Inc
INBS.O :
* INTELLIGENT BIO SOLUTIONS PARTNERS WITH CLIANTHA RESEARCH
TO
CONDUCT CLINICAL STUDY AS PART OF FDA 510(K) PATHWAY
Source text for Eikon: ID:nGNXqH01l
Further company coverage: INBS.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Intelligent Bio Solutions
See all newsBrief: Intelligent Bio Solutions Reports Fiscal 2026 Full-Year Revenue Growth Of 38% Year-Over-Year, Driven By Reader Installed Base And High-Margin Cartridge Growth
Brief: Intelligent Bio Solutions Initiates Clinical Study Supporting FDA Clearance And Planned US Market Entry
Intelligent Bio Solutions Q3 revenue rises 46%, gross margin tops 50%
Intelligent Bio Solutions rise after clearing security tests ahead of FDA filing
Brief: Intelligent Bio Solutions Completes Clinical Cut-Off Study